Hirawat Samit (CIK 0001781290)

Latest company ownership

BMY - BRISTOL MYERS SQUIBB CO
Role: EVP,Chief Med.Offr.,Drug Dev.
Shares held
83,513.49
Last filed at
Apr 29, 2025
Confidence Score
52.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 25, 2025 Apr 29, 2025 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Buy 90.0 +4,250 5.36% ✗ $202.2K
Mar 10, 2025 Mar 12, 2025 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Sell 17.5 -28,767 -4.70% ✗ $1M
Feb 14, 2025 Feb 19, 2025 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Buy 87.5 +1,823 2.94% ✗ $100K
Nov 1, 2024 Nov 5, 2024 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Buy 87.5 +1,830 3.04% ✗ $100.1K
Mar 10, 2024 Mar 12, 2024 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Sell 20.0 -25,354 -7.05% ✗ $734.2K
Jul 1, 2023 Jul 5, 2023 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Sell 20.0 -4,787 -9.20% ✗ $306.1K
Mar 10, 2023 Mar 14, 2023 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Sell 17.5 -17,595 -6.21% ✗ $1.5M
Jul 1, 2022 Jul 5, 2022 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Sell 20.0 -4,786 -18.35% ✗ $367.8K
Mar 10, 2022 Mar 14, 2022 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Sell 20.0 -4,104 -5.79% ✗ $356.1K
Jul 1, 2021 Jul 6, 2021 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Sell 20.0 -4,786 -28.94% ✗ $318.6K
Mar 10, 2021 Mar 12, 2021 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Sell 22.5 -1,900 -20.92% ✗ $120.5K
Jul 1, 2020 Jul 2, 2020 BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Sell 20.0 -4,463 -47.70% ✗ $265.2K